Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies.
Moffatt
S D
SD
Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom.
McAlister
V
V
Calne
R Y
RY
Metcalfe
S M
SM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology*; D004337:Drug Carriers; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006650:Histocompatibility Testing; D008081:Liposomes; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016827:CD8 Antigens; D004337:Drug Carriers; D008081:Liposomes; D016559:Tacrolimus